FIELD: medicine.
SUBSTANCE: invention is referred to medicine area, namely, to production of medical products. Preparations in the form of the stabilized solution, containing an antibody against a receptor of interleukine-6 or HM1.24, including sucrose as the stabilizer are offered. The specified preparations can additionally include surface-active substance as the stabilizer. Usage of the invention gives significant effect in prevention of association of molecules of the specified antibodies, during storage of solutions.
EFFECT: obtaining of preparations, containing antibodies.
8 cl, 18 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS OF HER2 ANTIBODY CONJUGATE | 2020 |
|
RU2795196C2 |
| SOLUTION PREPARATION CONTAINING STABILIZED ANTIBODIES | 2011 |
|
RU2653447C2 |
| PHARMACEUTICAL PREPARATION CONTAINING EGF RECEPTOR ANTIBODY | 2004 |
|
RU2381036C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING COMPLEX MARKING SITE - FAB-FRAGMENT OF ANTI-HUMAN ANTIBODY | 2019 |
|
RU2800924C2 |
| FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES | 2013 |
|
RU2683861C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO LAG-3 AND ITS USE | 2018 |
|
RU2771384C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ADALIMUMAB | 2014 |
|
RU2664736C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING BIOPHARMACEUTICAL DRUG | 2011 |
|
RU2587056C2 |
| COMPOSITIONS AND METHODS USED FOR STABILISATION OF PROTEIN-CONTAINING FINISHED FORMS | 2011 |
|
RU2584232C2 |
| PHARMACEUTICAL FORMULATION CONTAINING ADVANCED ANTIBODY MOLECULES | 2010 |
|
RU2565809C2 |
